Lon-TK
Lon-TK is a glycolysis inhibitor + linker conjugate of LTB (HY-169434). LTB is an intelligent responsive prodrug that connects Lonidamine (Lon) (HY-B0486) and a PD-L1 inhibitor (BMS-1, HY-19991) through a thioketal linker. It significantly inhibits the glycolytic metabolism of tumor cells and blocks the PD-1/PD-L1 immune escape pathway. Lon-TK shows potential for application in photodynamic-enhanced immunotherapy research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C24H28Cl2N2O3S2
- 分子量:527.53
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
化学情報
-
分子量 527.53
-
分子式 C24H28Cl2N2O3S2
-
SMILES
OCCCSC(C)(SCCCOC(C1=NN(C2=C1C=CC=C2)CC3=CC=C(C=C3Cl)Cl)=O)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
ホットトピック
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Process of PD-1/PD-L1-Mediated Tumor Immune Evasion
PD-1/PD-L1-mediated tumor immune evasion is a central mechanism by which tumors suppress antitumor immunity through immune checkpoint signaling.
2026-06-18
-
Topics Escape Route Built by TGF-β Signaling
Escape route built by TGF-β signaling refers to the immunosuppressive and stromal remodeling program through which tumors avoid immune elimination and reduce response to cancer immunotherapy.
2026-06-18
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)